Autoantibodies and Cardiovascular Dysfunction: Cause or Consequence?

被引:16
|
作者
Nagatomo Y. [1 ]
Tang W.H.W. [1 ,2 ]
机构
[1] Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
[2] Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland
基金
美国国家卫生研究院;
关键词
Autoantibody; Dilated cardiomyopathy; Muscarinic M2 acetylcholine receptor; Myosin; Peripartum cardiomyopathy; Preeclampsia; Troponin I; β1-Adrenergic receptor;
D O I
10.1007/s11897-014-0217-5
中图分类号
学科分类号
摘要
There has been a long history of the exploration into autoimmunity as a possible pathogenic factor of cardiovascular diseases from unknown cause represented by dilated cardiomyopathy (DCM). Autoantibodies (AAbs) have emerged either as humoral responses provoked by the release of “self-antigens” due to tissue damage or dysregulated humoral immunity itself. The pathogenic roles of some AAbs have been suggested by the findings from basic research using in vitro and in vivo disease models as well as clinical studies including immunoadsorption studies removing AAbs from patients with DCM. In this context, the importance of AAbs belonging to IgG3 subclass has also been implicated. In this review article, we summarize the findings accumulated to date regarding AAbs which have been considered to be involved in the pathology of DCM or pregnancy-related cardiovascular disease. Furthermore, we discuss the significance of AAbs as a possible cause of DCM and their potential roles as a novel therapeutic target. © 2014, Springer Science+Business Media New York.
引用
收藏
页码:500 / 508
页数:8
相关论文
共 50 条
  • [42] Cause or consequence?
    Volpe, Fernando Madalena
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (06)
  • [43] Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?
    Dumas, J. -F.
    Simard, G.
    Flamment, M.
    Ducluzeau, P. -H.
    Ritz, P.
    DIABETES & METABOLISM, 2009, 35 (03) : 159 - 167
  • [44] Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease
    Erickson, Michelle A.
    Banks, William A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (10): : 1500 - 1513
  • [45] The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease
    Polyzos, Aris A.
    McMurray, Cynthia T.
    MECHANISMS OF AGEING AND DEVELOPMENT, 2017, 161 : 181 - 197
  • [46] Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
    Lerman, Amir
    Holmes, David R.
    Herrmann, Joerg
    Gersh, Bernard J.
    EUROPEAN HEART JOURNAL, 2007, 28 (07) : 788 - 797
  • [47] Cardiovascular dysfunction as a common cause of mortality in hypereosinophilic syndromes
    Helbig, Grzegorz
    Hus, Marek
    Brzezniakiewicz-Janus, Katarzyna
    Woszczyk, Dariusz
    Lewandowski, Krzysztof
    Kyrcz-Krzemien, Slawomira
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (09): : 692 - 694
  • [48] White-coat hypertension as a cause of cardiovascular dysfunction
    Glen, SK
    Elliott, HL
    Curzio, JL
    Lees, KR
    Reid, JL
    LANCET, 1996, 348 (9028): : 654 - 657
  • [49] The innervation of the kidney in renal injury and inflammation: a cause and consequence of deranged cardiovascular control
    Abdulla, M. H.
    Johns, E. J.
    ACTA PHYSIOLOGICA, 2017, 220 (04) : 404 - 416
  • [50] Increased Serum Uric Acid: Consequence or Cause of Increased Cardiovascular Risk.
    Meek, Inger L.
    Vonkeman, Harald E.
    van de Laar, Mart A. F. J.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S70 - S70